RESET

Retatrutide

10mg/vial

A triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Currently one of the most actively studied compounds in metabolic research globally. What the research explores: appetite regulation pathways, metabolic rate studies, body composition research models. Why it's expensive: triple-receptor compounds are harder to synthesize and verify. Purity matters more here than almost anywhere else in the category.

This information is provided for research purposes only and does not constitute medical advice. IRIX products are not for human or animal consumption.